Iovance Biotherapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

이오밴스 바이오테라퓨틱스NASDAQ:IOVA · Nasdaq · Healthcare

$14.21-0.11%

2026-10-02 close

Iovance Biotherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $164M. 2024 operating profit was −$395M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy